CWCaroline J. Watson

Caroline J. Watson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Caroline J. Watson has a total of 152 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evolutionary dynamics in the years preceding acute myeloid leukaemia

    by Caroline J. Watson, Gladys Y. P. Poon, Hamish A. J. MacGregor, Adriana V. A. Fonseca, Sophia Apostolidou, Aristi Damaskou, Christopher Boniface, Samuel Hackett, Aleksandra Gentry-Maharaj, Usha Menon, et al.

    Somatic evolution in ageing tissues underlies many cancers 1,2 . However, our quantitative understanding of the rules governing this pre-cancerous evolution remains incomplete. Here we exploit a unique collection of serial blood samples 3 , collected annually for up to a decade and beginning as early as 15 years before diagnosis of acute myeloid leukaemia, to provide a quantitative description of pre-cancerous evolutionary dynamics. Using deep duplex sequencing and evolutionary theory, we quantify the acquisition ages and fitness effects of the key driver events in acute myeloid leukaemia development. The first driver mutations are typically acquired in the first few decades of life, when the blood remains highly polyclonal. These early slow-growing clones subsequently acquire multiple further driver mutations that confer selective advantages up to 100-fold larger than the early drivers. These faster-growing clones harbouring multiple driver mutations can cause complete somatic sweeps of the blood decades before diagnosis, a feature strongly associated with future acute myeloid leukaemia. Our data show that the clonal dynamics of blood are consistent with a set of remarkably simple evolutionary rules that strike a balance between chance and determinism.

  • Open Access

    In vivo lineage tracing across human tissues using methylation barcodes in the protocadherin gene cluster

    by Samuel F. Hackett, Christopher T. Boniface, Adriana V. A. Fonseca, Akemi D. Ramos-Yamasaki, Caroline Watson, Hannah M. L. Bazin, Amanda B. Tan, Henson Lee Yu, Lars L. P. Hanssen, Harveer Dev, et al.

    Resolving the lineage history of human cells is fundamental to understanding ageing and cancer but remains hampered by a lack of native, high-resolution markers. Here, we identify the protocadherin (PCDH) gene cluster as a naturally occurring, highly diverse methylation barcode. While PCDH methylation creates neuronal diversity in the brain, we show that stochastic methylation patterns in this region are maintained as heritable, evolvable lineage markers across multiple non-neuronal tissues, including blood, kidney, prostate, and bladder. By tracking these barcodes in serial samples over a decade, we reveal clonal dynamics with high fidelity, quantitatively recapitulating genetic clone sizes. Crucially, PCDH barcodes identify “cryptic” clonal expansions invisible to standard driver-mutation sequencing and resolve subclonal architectures via continuous epimutation. This native barcoding system provides a scalable, driver-agnostic framework for reconstructing somatic evolution in humans.


  • Open Access

    Can Wearable Technologies Assist in the Earlier Detection of Cancer?

    by Valerie A Sills, Kirsten L Rennie, Nina M Rzechorzek, Caroline J Watson, Suzanne E Scott, Joss Langford, Wendy Alderton, Nan Li, Cecilia Mascolo, Veronica Martinez-Hernandez, et al.

    There is considerable interest in smart wearable technologies, and the field is rapidly expanding, with the main driver for the market growth being demand for sports, fitness, and lifestyle applications. Wearables are increasingly being used in health applications, since they provide the opportunity to continuously measure movement alongside physiological data resulting in rich, longitudinal information. A particular area of interest is whether wearables can assist in the early detection of disease. Cancer is one disease area where early detection is known to make a significant difference to outcomes and survival rates. Wearables are potential tools that could assist earlier detection of cancers. A one-day workshop organised by the Early Cancer Institute and the Precision Health Initiative of the University of Cambridge was held on 20th October 2023 in Cambridge, UK to focus on the posed question ‘Can Cancer be Detected Earlier by Employing Wearable Technologies?’. This workshop reviewed the state of the field and aimed to identify areas for future research. It brought together data scientists, engineers, clinicians, computer scientists, physicists, psychologists, life scientists, industry representatives, patient and public representatives, and funders. This report brings together the collective thinking from the workshop and highlights the challenges faced and considerations for future work in the field of using wearables to assist in early detection of cancer. The complexity of this space is not to be underestimated and key to success are early consideration of acceptability, privacy, data security, and equity alongside technology development.

  • Open Access

    Author Correction: Clonal dynamics and somatic evolution of haematopoiesis in mouse

    by Chiraag D. Kapadia, Nicholas Williams, Kevin J. Dawson, Caroline Watson, Matthew J. Yousefzadeh, Duy Le, Kudzai Nyamondo, Sreeya Kodavali, Alex Cagan, Sarah Waldvogel, et al.

  • Top Cited Papers
    Open Access

    Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy

    by Jie Liu, Jie Liu, Duc Tran, Duc Tran, Liying Xue, Liying Xue, Brian J. Wiley, Brian J. Wiley, Caitlyn Vlasschaert, Caitlyn Vlasschaert, et al.

    With age, clonal expansions occur pervasively across normal tissues yet only in rare instances lead to cancer, despite being driven by well-established cancer drivers. Characterization of the factors that influence clonal progression is needed to inform interventional approaches. Germline genetic variation influences cancer risk and shapes tumor mutational profile, but its influence on the mutational landscape of normal tissues is not well known. Here we studied the impact of germline genetic variation on clonal hematopoiesis (CH) in 731,835 individuals. We identified 22 new CH-predisposition genes, most of which predispose to CH driven by specific mutational events. CH-predisposition genes contribute to unique somatic landscapes, reflecting the influence of germline genetic backdrop on gene-specific CH fitness. Correspondingly, somatic–germline interactions influence the risk of CH progression to hematologic malignancies. These results demonstrate that germline genetic variation influences somatic evolution in the blood, findings that likely extend to other tissues.


  • Open Access

    Methylation dynamics in the decades preceding acute myeloid leukaemia

    by Adriana V.A. Fonseca, Christopher Boniface, Caroline J. Watson, Samuel Hackett, Calum Gabbutt, Akemi D. Ramos-Yamasaki, Amanda B. Tan, Jose Montoya, Ruslan Strogantsev, Lars L. P. Hanssen, et al.

    DNA methylation is emerging as a highly sensitive and specific marker of cancer initiation and progression. How these cancer-specific methylation changes are established in the decades before cancer, however, remains largely unknown. Here, we use a unique collection of longitudinal blood samples collected annually up to 15 years prior to a diagnosis of acute myeloid leukaemia to sensitively track the dynamics of DNA methylation changes at high temporal resolution. We identify thousands of differentially methylated regions (DMRs) that exhibit altered patterns of methylation up to 10 years before acute myeloid leukaemia (AML) diagnosis. Most of these DMRs are strongly associated with expanding clones carrying somatic driver mutations. We identify a subset of ‘epigenetic driver’ DMRs characterised by recurrent CpG alterations that are highly shared across pre-AML cases. These are likely to reflect early epigenetic reprogramming associated with AML development. We also reveal large numbers of stochastic ‘passenger’ CpGs whose differential methylation results from hitch-hiking with clonal expansions driven by somatically acquired genetic events. These passenger CpGs can be exploited for lineage tracing to discover clonal expansions driven by missing driver mutations. Our findings show widespread changes in methylation patterns during the early stages of cancer development which could be utilised for risk prediction and therapeutic intervention.


  • Top Cited Papers
    Open Access

    Clonal dynamics and somatic evolution of haematopoiesis in mouse

    by Chiraag D. Kapadia, Nicholas Williams, Kevin J. Dawson, Caroline Watson, Matthew J. Yousefzadeh, Duy Le, Kudzai Nyamondo, Sreeya Kodavali, Alex Cagan, Sarah Waldvogel, et al.

    Haematopoietic stem cells maintain blood production throughout life1. Although extensively characterized using the laboratory mouse, little is known about clonal selection and population dynamics of the haematopoietic stem cell pool during murine ageing. We isolated stem cells and progenitors from young and old mice, identifying 221,890 somatic mutations genome-wide in 1,845 single-cell-derived colonies. Mouse stem cells and progenitors accrue approximately 45 somatic mutations per year, a rate only approximately threefold greater than human progenitors despite the vastly different organismal sizes and lifespans. Phylogenetic patterns show that stem and multipotent progenitor cell pools are established during embryogenesis, after which they independently self-renew in parallel over life, evenly contributing to differentiated progenitors and peripheral blood. The stem cell pool grows steadily over the mouse lifespan to about 70,000 cells, self-renewing about every 6 weeks. Aged mice did not display the profound loss of clonal diversity characteristic of human haematopoietic ageing. However, targeted sequencing showed small, expanded clones in the context of murine ageing, which were larger and more numerous following haematological perturbations, exhibiting a selection landscape similar to humans. Our data illustrate both conserved features of population dynamics of blood and distinct patterns of age-associated somatic evolution in the short-lived mouse.


  • Open Access

    Evolutionary dynamics in the decades preceding acute myeloid leukaemia

    by Caroline J. Watson, Gladys Y. P. Poon, Hamish A.J. MacGregor, Adriana V.A. Fonseca, Sophia Apostolidou, Aleksandra Gentry-Maharaj, Usha Menon, Jamie R. Blundell

    Somatic evolution in ageing tissues underlies many cancers. However, our quantitive understanding of the rules governing this pre-cancerous evolution remains incomplete. Here we exploit a unique collection of serial blood samples collected annually up to 15 years prior to diagnosis of acute myeloid leukaemia (AML) to provide a quantitative description of pre-cancerous evolutionary dynamics. Using deep duplex sequencing and evolutionary theory, we quantify the acquisition ages and fitness effects of the key driver events in AML development. The first driver mutations are typically acquired in the first few decades of life when the blood remains highly polyclonal. These early slow-growing clones subsequently acquire multiple further driver mutations which confer selective advantages up to 100-fold larger than the early drivers. These faster-growing clones harbouring multiple driver mutations can cause complete somatic sweeps of the blood decades before diagnosis, a feature strongly associated with future AML. Once established in the blood, the dynamics of driver mutations are highly predictable. Trajectories are shaped by strong clonal competition between lineages with limited evidence of other extrinsic factors playing a major role. Our data show that the clonal dynamics of blood are consistent with a set of remarkably simple evolutionary rules which strike a balance between chance and determinism.


  • The 2023 generation

    by Joanna Achinger-Kawecka, Santiago Correa, Jing Hu, Gaopeng Li, Rik G. H. Lindeboom, Sandra Misale, Teresa Monkkonen, Ajit J. Nirmal, Stefan Prekovic, Sanju Sinha, et al.